E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/11/2005 in the Prospect News Biotech Daily.

HemoBioTech common stock quoted on OTC Bulletin Board

By Angela McDaniels

Seattle, Nov. 11 - HemoBioTech Inc. said that quotations for its common stock began on the OTC Bulletin Board on Thursday under the ticker symbol "HMBT".

The stock closed at $1.30 on Friday.

Dallas-based HemoBioTech is the developer of HemoTech, a human blood substitute.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.